Prophylactic vs preemptive oral valganciclovir for management of cytomegalovirus infection in adult renal transplant recipients: a clinical and pharmacoeconomic study
Phase of Trial: Phase III
Latest Information Update: 22 Oct 2006
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 22 Oct 2006 New trial record.